Direct Fed Microbial Market Top Companies Analysis to Reach $1.77 Billion Your Business by 2026

Direct-fed microbial contains live bacterial strains that help in the growth and development of animals. These beneficial organisms are replacing the use of antibiotics.

The global direct fed microbial market size was valued at $980 million in 2018, and is expected to reach $1,772 million by 2026, registering a CAGR of 7.5% from 2019 to 2026.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6494

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

However, due to the risk of development of antimicrobial-resistant organisms, the use of antibiotics as growth promoters for animal production has been banned. The administration of direct-fed microbial help to enhance the meat and milk production in animals such as cattle and poultry. In addition, these products modulate the immune response of animals and inhibit the growth of pathogenic organisms in the gastrointestinal tract of animals.

Increase in demand for meat & milk consumption and rise in profitability at same cost are the major factors driving the market growth of direct fed microbial market. Furthermore, significant surge in human population and increase in demand for protein content in the diet propel the market growth for direct-fed microbial. In addition, probiotics aid nutrient absorption by breaking down the complex compounds, which, in turn, helps to reduce the cost of animal production and increases the profitability of the animal producers. However, enforcement of stringent regulations regarding the vigorous usage of these microorganisms in animal diet and increase in cost of production are the major factors hampering thedirect fed microbial market growth. Conversely, ban on the usage of antibiotics in animal diet in the developed nations such the U.S., Germany, and the UK and rise in animal health concerns are anticipated to offer remunerative opportunities for market expansion in the near future.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6494

By product, the lactobacillus segment accounted for 62% of the total direct fed microbial market share in 2018, and is expected to exhibit a prominent growth rate in the near future, owing to its increased usage in the livestock diet. Lactobacillus is the most widely used probiotics in the livestock diet, as it is considered safe and more beneficial as compared to the other bacterial species.

By livestock, the poultry segment dominated the direct fed microbial market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the fact that poultry is the most consumed animal meat across the globe. Furthermore, individuals prefer poultry other than other livestock animals.

By region, North America accounted for the major direct fed microbial market share in 2018 and is expected to continue this trend, owing to easy availability of direct fed microbial products. Moreover, surge in the demand for probiotics and rise in awareness towards maintenance of healthy lifestyle in the region are the major reason that contributes to the growth of this market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the increase in awareness regarding the use of direct fed microbial.

Access Full Report @ https://www.alliedmarketresearch.com/direct-fed-microbial-market-A06129

The Major Key Players Are:
• Koninklijke DSM N. V
• Bio-Vet
• Archer-Daniels-Midland Company
• CHR. Hansen A/S
• E. I. Du Pont De Nemours And Company
• Novozymes A/S
• Kemin Industries, Inc.
• BASF SE (BASF Corporation)
• Evonik Industries Ag
• Adisseo.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.